Nautilus Neurosciences
Latest round
- Series A
Last raised
- Apr 2010
Total raised
- $25M
Investors
- 2
About Nautilus Neurosciences
Founded in 2009 in the United States, Nautilus Neurosciences Inc specializes in neurological treatments. The company underwent a significant pivot in 2013 when it sold the rights to its product CAMBIA (diclofenac potassium for oral solution) to Depomed, Inc.7 mn.Nautilus Neurosciences Inc offers a range of therapeutic products focused on addressing challenges in neurological healthcare. Its core offerings include specialized pharmaceutical solutions targeting conditions like migraine, which are designed to improve treatment efficacy and patient quality of life.The revenue model of Nautilus Neurosciences Inc is primarily based on direct sales of its pharmaceutical products to healthcare providers and patients. This model allows the company to maintain flexibility and adapt to market demands while addressing specific therapeutic needs through its offerings.Looking ahead, Nautilus Neurosciences Inc plans to expand its product pipeline by developing new therapeutic solutions for additional neurological conditions, with anticipated releases in the coming years. The firm is also targeting growth in European markets, aiming to establish a more significant presence by 2025. The proceeds from the most recent deal, which was completed in December 2013, will be utilized to support these initiatives, including research and development for new product launches.
Who invested in Nautilus Neurosciences
2 investors across 2 rounds
See all investors in Nautilus Neurosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nautilus Neurosciences
Who invested in Nautilus Neurosciences?
Nautilus Neurosciences has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nautilus Neurosciences raised?
Nautilus Neurosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nautilus Neurosciences last raise money?
Nautilus Neurosciences's most recent round on record is a Series A, in Apr 2010.
What does Nautilus Neurosciences do?
Founded in 2009 in the United States, Nautilus Neurosciences Inc specializes in neurological treatments.
Where is Nautilus Neurosciences headquartered?
Nautilus Neurosciences is headquartered in US.
Which VCs invest in companies like Nautilus Neurosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Nautilus Neurosciences's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Nautilus Neurosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.